Skip to main content
Clinical Trials/DRKS00029210
DRKS00029210
Not yet recruiting
Not Applicable

Hyperspectral imaging as monitoring of cutaneous microcirculatory responsiveness in patients with sepsis. - HySpISepsis

Klinik für Anästhesiologie und IntensivmedizinUniversitätsklinikum Essen0 sites50 target enrollmentDecember 22, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
A41.9
Sponsor
Klinik für Anästhesiologie und IntensivmedizinUniversitätsklinikum Essen
Enrollment
50
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Anästhesiologie und IntensivmedizinUniversitätsklinikum Essen

Eligibility Criteria

Inclusion Criteria

  • Written declaration of consent by the legal representative
  • \- Inclusion according to the regulations of the consiliary physician procedure
  • \- age \> 18 years
  • \- sepsis according to sepsis\-3 definition
  • \- invasive ventilation

Exclusion Criteria

  • \- Age \< 18 years
  • \- Refusal to participate in the study
  • \- Patient likely to be transferred from ICU within first 72 hours of study inclusion
  • \- Palliative therapeutic approach
  • \- Existing therapy goal limitation
  • \- Death of the patient is already foreseeable or inevitable at study inclusion
  • \- Dark skin type (methodological limitation for cutaneous hyperspectral imaging)

Outcomes

Primary Outcomes

Not specified

Similar Trials